The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro

Elisa Boanini, Paola Torricelli, Massimo Gazzano, Milena Fini, Adriana Bigi

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

This study demonstrates that zoledronate containing hydroxyapatite nanocrystals (HA-ZOL) can be synthesized as a single crystalline phase up to a zoledronate content of about 7 wt% by direct synthesis in aqueous solution, at variance with what previously found for alendronate-hydroxyapatite nanocrystals (HA-AL). On increasing zoledronate incorporation, the length of the coherent crystalline domains and the crystal dimensions of hydroxyapatite decrease, whereas the specific surface area increases. Full profile fitting of the powder X-ray diffraction patterns does not indicate major structural modifications, but an increase of the hydroxyapatite unit cell, on increasing zoledronate content. These data, together with a structural similarity between hydroxyapatite and calcium zoledronate, suggest a preferential interaction between zoledronate and the hydroxyapatite faces parallel to the c-axis direction. Osteoblast-like MG-63 cells and human osteoclasts were cultured on HA-ZOL nanocrystals and as a comparison on HA-AL nanocrystals containing almost the same (about 7 wt%) bisphosphonate amount. The beneficial influence of bisphosphonates on osteoblast proliferation and differentiation is enhanced when the tests are performed in co-cultures. Similarly, the reduction of osteoclast proliferation and the increase of Caspase 3 production are dramatically enhanced in co-cultures, which highlight an even greater influence of HA-ZOL than HA-AL on osteoclast apoptosis.

Original languageEnglish
Pages (from-to)722-730
Number of pages9
JournalBiomaterials
Volume33
Issue number2
DOIs
Publication statusPublished - Jan 2012

Fingerprint

zoledronic acid
Nanocomposites
Osteoblasts
Osteoclasts
Durapatite
Hydroxyapatite
Nanoparticles
Nanocrystals
Diphosphonates
Coculture Techniques
Crystalline materials
Alendronate
Cell death
X-Ray Diffraction
Specific surface area
Caspase 3
Powders
Diffraction patterns
In Vitro Techniques
Calcium

Keywords

  • Bisphosphonates
  • Co-cultures
  • Hydroxyapatite
  • Osteoblast
  • Osteoclast

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro. / Boanini, Elisa; Torricelli, Paola; Gazzano, Massimo; Fini, Milena; Bigi, Adriana.

In: Biomaterials, Vol. 33, No. 2, 01.2012, p. 722-730.

Research output: Contribution to journalArticle

@article{532f1a0a6ac54c70acfed5ce875c96fd,
title = "The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro",
abstract = "This study demonstrates that zoledronate containing hydroxyapatite nanocrystals (HA-ZOL) can be synthesized as a single crystalline phase up to a zoledronate content of about 7 wt{\%} by direct synthesis in aqueous solution, at variance with what previously found for alendronate-hydroxyapatite nanocrystals (HA-AL). On increasing zoledronate incorporation, the length of the coherent crystalline domains and the crystal dimensions of hydroxyapatite decrease, whereas the specific surface area increases. Full profile fitting of the powder X-ray diffraction patterns does not indicate major structural modifications, but an increase of the hydroxyapatite unit cell, on increasing zoledronate content. These data, together with a structural similarity between hydroxyapatite and calcium zoledronate, suggest a preferential interaction between zoledronate and the hydroxyapatite faces parallel to the c-axis direction. Osteoblast-like MG-63 cells and human osteoclasts were cultured on HA-ZOL nanocrystals and as a comparison on HA-AL nanocrystals containing almost the same (about 7 wt{\%}) bisphosphonate amount. The beneficial influence of bisphosphonates on osteoblast proliferation and differentiation is enhanced when the tests are performed in co-cultures. Similarly, the reduction of osteoclast proliferation and the increase of Caspase 3 production are dramatically enhanced in co-cultures, which highlight an even greater influence of HA-ZOL than HA-AL on osteoclast apoptosis.",
keywords = "Bisphosphonates, Co-cultures, Hydroxyapatite, Osteoblast, Osteoclast",
author = "Elisa Boanini and Paola Torricelli and Massimo Gazzano and Milena Fini and Adriana Bigi",
year = "2012",
month = "1",
doi = "10.1016/j.biomaterials.2011.09.092",
language = "English",
volume = "33",
pages = "722--730",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro

AU - Boanini, Elisa

AU - Torricelli, Paola

AU - Gazzano, Massimo

AU - Fini, Milena

AU - Bigi, Adriana

PY - 2012/1

Y1 - 2012/1

N2 - This study demonstrates that zoledronate containing hydroxyapatite nanocrystals (HA-ZOL) can be synthesized as a single crystalline phase up to a zoledronate content of about 7 wt% by direct synthesis in aqueous solution, at variance with what previously found for alendronate-hydroxyapatite nanocrystals (HA-AL). On increasing zoledronate incorporation, the length of the coherent crystalline domains and the crystal dimensions of hydroxyapatite decrease, whereas the specific surface area increases. Full profile fitting of the powder X-ray diffraction patterns does not indicate major structural modifications, but an increase of the hydroxyapatite unit cell, on increasing zoledronate content. These data, together with a structural similarity between hydroxyapatite and calcium zoledronate, suggest a preferential interaction between zoledronate and the hydroxyapatite faces parallel to the c-axis direction. Osteoblast-like MG-63 cells and human osteoclasts were cultured on HA-ZOL nanocrystals and as a comparison on HA-AL nanocrystals containing almost the same (about 7 wt%) bisphosphonate amount. The beneficial influence of bisphosphonates on osteoblast proliferation and differentiation is enhanced when the tests are performed in co-cultures. Similarly, the reduction of osteoclast proliferation and the increase of Caspase 3 production are dramatically enhanced in co-cultures, which highlight an even greater influence of HA-ZOL than HA-AL on osteoclast apoptosis.

AB - This study demonstrates that zoledronate containing hydroxyapatite nanocrystals (HA-ZOL) can be synthesized as a single crystalline phase up to a zoledronate content of about 7 wt% by direct synthesis in aqueous solution, at variance with what previously found for alendronate-hydroxyapatite nanocrystals (HA-AL). On increasing zoledronate incorporation, the length of the coherent crystalline domains and the crystal dimensions of hydroxyapatite decrease, whereas the specific surface area increases. Full profile fitting of the powder X-ray diffraction patterns does not indicate major structural modifications, but an increase of the hydroxyapatite unit cell, on increasing zoledronate content. These data, together with a structural similarity between hydroxyapatite and calcium zoledronate, suggest a preferential interaction between zoledronate and the hydroxyapatite faces parallel to the c-axis direction. Osteoblast-like MG-63 cells and human osteoclasts were cultured on HA-ZOL nanocrystals and as a comparison on HA-AL nanocrystals containing almost the same (about 7 wt%) bisphosphonate amount. The beneficial influence of bisphosphonates on osteoblast proliferation and differentiation is enhanced when the tests are performed in co-cultures. Similarly, the reduction of osteoclast proliferation and the increase of Caspase 3 production are dramatically enhanced in co-cultures, which highlight an even greater influence of HA-ZOL than HA-AL on osteoclast apoptosis.

KW - Bisphosphonates

KW - Co-cultures

KW - Hydroxyapatite

KW - Osteoblast

KW - Osteoclast

UR - http://www.scopus.com/inward/record.url?scp=80055110896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055110896&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2011.09.092

DO - 10.1016/j.biomaterials.2011.09.092

M3 - Article

C2 - 22014461

AN - SCOPUS:80055110896

VL - 33

SP - 722

EP - 730

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 2

ER -